Seminars in Oncology Nursing
Volume 22, Issue 2 , Pages 107-116 , May 2006

Hematopoietic Cell Transplantation in Non-Hodgkin’s Lymphoma

  • Sharon K. Steingass

      Affiliations

    • Corresponding Author InformationAddress correspondence to Sharon K. Steingass, RN, MSN, AOCN®, Clinical Practice and Professional Education, City of Hope National Medical Center, 1500 E. Duarte Rd, Duarte, CA 91010

References 

  1. American Cancer Society . Cancer Facts and Figures 2006 . Atlanta, GA: American Cancer Society; 2006;
  2. Dana BW , Dahlbert S , Nathwani BN , et al.   Long-term follow-up of patients with low grade malignant lymphoma treated with doxorubicin based chemotherapy or chemoimmunotherapy . J Clin Oncol . 1993;11: 664-651
  3. Bruce WR , Meeker BE , Valeriote FA . Comparison of sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo . J Natl Cancer Inst . 1965;37:233–245
  4. Appelbaum FR , Deisseseroth AB , Graw RG , et al.   Prolonged complete remission following high dose chemotherapy of Burkitt’s lymphoma in relapse . Cancer . 1978;41:1059–1063
  5. Vos JM , Anderson JR , Kessinger A . High dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin’s lymphoma . J Clin Oncol . 1993;11:1846–1851
  6. Mills W , Chopra R , McMillian A , et al.   BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin’s lymphoma . J Clin Oncol . 1995;13:588–595
  7. Philip T , Armitage JO , Spitzer G . High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin’s lymphoma . N Engl J Med . 1987;316:1493–1498
  8. Philip T , Guglielmi C , Hagenbeek A , et al.   Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma . N Engl J Med . 1995;333:1540–1545
  9. Guglielmi C , Gomez F , Philip T , et al.   Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial . J Clin Oncol . 1998;16:3264–3269
  10. Haioun C , Lepage E , Gisselbrecht C , et al.  Groupe d’Etude des Lymphomes de I’Adulte   Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin’s lymphoma in first complete remission (A study of 464 patients) . J Clin Oncol . 2004;12:2543–2551
  11. Gulati SC , Shank B , Blac P , et al.   Autologous bone marrow transplantation for patients with poor prognosis lymphoma . J Clin Oncol . 1988;6:1303–1313
  12. Nademanee A , Molina A , O’Donnell MR , et al.   Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor risk intermediate and high grade lymphoma. International index high and high-intermediate risk group . Blood . 1997;90:3844–3852
  13. Salzman DE , Biggs A , Vaughn WP . Bone marrow transplantation for non-Hodgkin’s lymphoma (A review) . Am J Med Sci . 1997;313:228–235
  14. Freedman AS , Neuberg D , Mauch P , et al.   Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma . Blood . 1999;94:3325–3333
  15. Cao TM , Horning S , Negrin RS , et al.   High-dose therapy and autologous cell transplantation for follicular lymphoma beyond first remission (The Stanford University experience) . Biol Blood Marrow Transplant . 2001;7:294–301
  16. Gribben JG , Freedman AS , Woo SE , et al.   All advanced stage non-Hodgkin’s lymphomas with polymerase chain reaction amplification breakpoint of bcl-2 have residual cells containing bcl-2 rearrangement at evaluation after treatment . Blood . 1991;78:3275–3280
  17. Bernstein NL , Reis MD , Ngan BY , et al.   Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma . J Clin Oncol . 1993;11:1344–1352
  18. Molina A , Kraft D , Carter N . Autologous stem cell transplantation for mantle cell lymphoma (A report of 69 patients from City of Hope and Stanford (abstract)) . Proc Am Soc Hematol . 2002;100:182a
  19. Gopal AK , Rajendran JG , Petersdorf SH , et al.   High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma . Blood . 2002;99:3158–3162
  20. Rodriguez J , Munssell M , Yazji S , et al.   Impact of high-dose chemotherapy on peripheral T-cell lymphomas . J Clin Oncol . 2001;19:3766–3770
  21. Levine AM . Acquired immunodeficiency syndrome-related lymphoma (Clinical aspects) . Semin Oncol . 2000;27:442–453
  22. Kaplan LD , Straus DJ , Testa MA , et al.  National Institute of Allergy and Infectious Diseases ADIS Clinical Trials Group   Low dose compared with standard dose m-BACOD chemotherapy for non-Hodgkin’s lymphoma associated with human immunodeficiency virus infection . N Engl J Med . 1997;366:1641–1648
  23. Bowen RA , Coombs RW , Nikora BH . Progression of human immunodeficiency virus type-1 infection after allogeneic marrow transplantation . Am J Med . 1990;88:49N–52N
  24. Gabarre J , Leglond V , Suggon L , et al.   Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin’s lymphoma . Bone Marrow Transplant . 1996;18:1195–1197
  25. Benicchi T , Ghidini C , Allessandro RE , et al.   T-cell immune reconstitution after hematopoietic stem cell transplantation of HIV associated lymphoma . Transplantation . 2005;80:673–682
  26. Schouten HD , Qian W , Kvaloy S , et al.   High-dose therapy improved progression-free survival and survival in relapsed follicular non-Hodgkin’s lymphoma (Results from the randomized European CUP trial) . J Clin Oncol . 2003;21:3918–3927
  27. Williams CD , Goldstone AH , Pearce RM , et al.   Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin’s lymphoma (A case-matches comparison with unpurged cases by the European blood and marrow transplant lymphoma registry) . J Clin Oncol . 1996;14:2454–2464
  28. Maloney DG , Liles TM , Czerwinski DK , et al.   Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B cell lymphoma . Blood . 1994;83:435–445
  29. Vose JM , Shart G , Chan WD , et al.   Autologous transplantation for aggressive non-Hodgkin’s lymphoma (Results of a randomized trial evaluating graft source and minimal residual disease) . J Clin Oncol . 2002;20:2344–2352
  30. Demirkazik A , Kessinger A , Armitag JO , et al.   Progenitor and lymphoma cells in blood stem cell harvests (Impact on survival following transplantation) . Bone Marrow Transplant . 2001;28:207–212
  31. Sharp JG , Man S , Murphy B , et al.   Culture methods for the detection of minimal tumor contamination of hematopoietic harvests (A review) . J Hematother . 1995;4:141–148
  32. Hartmann O , Le Corroller AG , Blaise D , et al.   Peripheral blood for solid tumors and lymphomas (Hematologic recovery and costs – A randomized controlled trial) . Ann Intern Med . 1997;126:600–607
  33. Schmitz N , Linch DC , Dreger P , et al.   Randomized trial of Filgrastim-mobilized peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients . Lancet . 1996;347:353–357
  34. Verdonck LF , Dekker AW , Lokhort HM , et al.   Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin’s lymphoma . Blood . 1997;90:4201–4205
  35. van Bensien K , Sobocinski KA , Rowlings PA , et al.   Allogeneic bone marrow transplantation for low grade lymphoma . Blood . 1998;92:1832–1836
  36. Horning S , Nademanee A . Autologous hematopoietic cell transplantation for non-Hodgkin’s lymphoma . In:  Thomas ED ,  Blume K ,  Forman S editor. Hematopoietic Cell Transplantation . Malden, MA: Blackwell Sciences; 1994;p. 939–949
  37. Press OW , Eary JF , Gooley T , et al.   A phase I-II trial of iodine-131-tositumomab (anti CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas . Blood . 2000;96:2934–2942
  38. Liu SY , Eary JF , Petersdorf SH , et al.   Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-sell rescue . J Clin Oncol . 1998;16:3270–3278
  39. Simpson JK . Specialized nursing . In:  Ball ED ,  Lister J ,  Law P editor. Hematopoietic Stem Cell Therapy . New York, NY: Churchill Livingstone; 2000;p. 683–687
  40. Applebaum FR . Graft versus disease versus graft-versus host disease . In: Improving the therapeutic index . Alexandria, VA: American Society of Clinical Oncology 2002 Spring Education; 2002;p. 62–67
  41. Mitchell SA . Graft versus host disease . In:  Ezzone S editors. Hematopoietic Stem Cell Transplantation (A Manuel for Nursing Practice) . Pittsburgh, PA: Oncology Nursing Society; 2004;p. 85–131
  42. Ezzone SA . Patient and family caregiver teaching . In:  Buchsel P ,  Kapustay PM editor. Stem Cell Transplantation (A clinical Textbook) . Pittsburgh, PA: Oncology Nursing Society; 2000;p. 6.1–6.11
  43. Buchsel PC . Bone marrow transplantation . In:  Miaskowski C ,  Buchsel P editor. Oncology Nursing (Assessment and Clinical Care) . St Louis, MO: Mosby; 1999;p. 143–186
  44. Williams L . Post transplant follow up . In:  Ezzone S editors. Hematopoietic Stem Cell Transplantation (A Manuel for Nursing Practice) . Pittsburgh, PA: Oncology Nursing Society; 2004;p. 207–220
  45. Holmes W . Quality of life issues in hematopoietic stem cell transplantation . In:  Ezzone S editors. Hematopoietic Stem Cell Transplantation (A Manuel for Nursing Practice) . Pittsburgh, PA: Oncology Nursing Society; 2004;p. 237–248
  46. Khouri I , Champlin R . Allogeneic transplantation for lymphoma and chronic lymphocytic leukemia . In:  Blume K ,  Forman S ,  Applebaum F editor. Thomas’ Hematopoietic Cell Transplantation . Malden, MA: Blackwell; 2004;p. 1104–1113

PII: S0749-2081(06)00015-5

doi: 10.1016/j.soncn.2006.01.006

Seminars in Oncology Nursing
Volume 22, Issue 2 , Pages 107-116 , May 2006